Springfield Public Schools is offering the free WheresTheBus app for all parents of bus riders. They can see the route and ...

It isn't a cheap buy, but given its strong growth prospects, a premium is justifiable. Lilly could obtain approval for a weight loss pill that would unlock even more growth. Investors should never ...

Learn More » For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45 ...

XploreRide makes a loop around Waikiki and Diamond Head while passengers interact with a virtual environment via cross ...

It might be a small world, but big changes are in store for guests of Disneyland’s Main Street U.S.A. and its "It’s A Small World" attraction. The resort is celebrating its 70th anniversary ...

Eli Lilly has opened up a second market for its new Alzheimer's disease therapy Kisunla, after Japan followed the US in approving the drug. Kisunla (donanemab) is the second in a new generation of ...

Eli Lilly has chalked up another regulatory approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest pharma market. The National Medical ...

The Marvel Cinematic Universe may have begun in 2008 with Iron Man, a billionaire playboy genius and philanthropist who fights injustice. But over the course of 16 years and 30-plus movies, the MCU ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Eli Lilly and Company (NYSE: LLY) announced results from the VIVID-2 open-label extension study, which showed the majority of patients with moderately to severely active Crohn's disease receiving ...